{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:54:43Z","timestamp":1762898083216,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.maturitas.2005.02.020","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T17:50:49Z","timestamp":1112896249000},"page":"98-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk"],"prefix":"10.1016","volume":"51","author":[{"given":"Rogerio A.","family":"Lobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2005.02.020_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of post-menopausal hormone therapy: annual trends and response recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2005.02.020_bib2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.fertnstert.2004.02.095","article-title":"The Women's health initiative could not have detected cardioprotective effect of starting hormone therapy during the menopausal transition","volume":"81","author":"Naftolin","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2005.02.020_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.gyobfe.2004.03.012","article-title":"Effects of HRT on the risks of breast cancer and cardiovascular disease: the validity of the epidemiological evidence","volume":"32","author":"Shapiro","year":"2004","journal-title":"Gyn Obstet Fertil"},{"key":"10.1016\/j.maturitas.2005.02.020_bib4","series-title":"Climacteric medicine\u2014where do we go?","first-page":"154","article-title":"Observational studies and randomized clinical trials of hormone therapy: effect of stage of menopause on outcomes","author":"Lobo","year":"2005"},{"issue":"25","key":"10.1016\/j.maturitas.2005.02.020_bib5","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","article-title":"Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen\/Progestin Replacement study (HERS)","volume":"105","author":"Herrington","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.maturitas.2005.02.020_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.maturitas.2005.02.020_bib7","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy post-menopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"issue":"9382","key":"10.1016\/j.maturitas.2005.02.020_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Million women study collaborators. Breast cancer and hormone-replacement therapy in the Million Women study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2005.02.020_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1991.00400010089011","article-title":"Menopausal estrogen replacement therapy and breast cancer","volume":"151","author":"Dupont","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib10","first-page":"955","article-title":"Evaluation of cardiovascular-event rates with hormone replacement therapy in healthy post-menopausal women","volume":"101","author":"Lobo","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archinte.164.5.482","article-title":"Evaluation of cardiovascular event rates with hormone therapy in healthy, early post-menopausal women: Results from two large clinical trials","volume":"164","author":"Lobo","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(00)00952-9","article-title":"Divergent effects of hormone therapy on serum markers of inflammation in post-menopausal women with coronary artery disease on appropriate medical management","volume":"36","author":"Zanger","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of post-menopausal hormone therapy and primary prevention of cardiovascular disease","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0029-7844(96)00272-4","article-title":"Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms","author":"Speroff","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower-doses of conjugated equine estrogens and medroxy-progesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2005.02.020_bib16","first-page":"293","article-title":"Efficacy on climacteric symptoms and safety of low-dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study","volume":"50","author":"deAloysio","year":"2000","journal-title":"Drug Res"},{"issue":"Suppl.","key":"10.1016\/j.maturitas.2005.02.020_bib17","first-page":"498","article-title":"The effects of progestins on vasomotor flushes","volume":"27","author":"Schiff","year":"1982","journal-title":"J Reprod Med."},{"key":"10.1016\/j.maturitas.2005.02.020_bib18","first-page":"15","article-title":"Effects of estrogen therapy on vaginal physiology during menopause","volume":"66","author":"Semmens","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5122(92)90246-Z","article-title":"Low-dose oestradiol in the treatment of urogenital estrogen deficiency\u2014a pharmacokinetic and pharmacodynamic study","volume":"15","author":"Nilsson","year":"1992","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.02.020_bib20","first-page":"191","article-title":"Ultra-low-dose transdermal estrogen therapy in post-menopausal urogenital estrogen deficiency\u2014a placebo-controlled study","volume":"1","author":"Nilsson","year":"1994","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2005.02.020_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","article-title":"A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in post-menopausal women with symptoms and signs of urogenital aging","volume":"174","author":"Henriksson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00042192-200007030-00002","article-title":"Urogenital atrophy and low-dose vaginal estrogen therapy","volume":"7","author":"Notelovitz","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2005.02.020_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogenous hormones and the risk of hip and vertebral fractures among older women","volume":"339","author":"Cummings","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib24","first-page":"2239","article-title":"Associations between low levels of serum estradiol, bone density, and fractures","volume":"83","author":"Ettinger","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2005.02.020_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00316876","article-title":"Minimal levels of serum estradiol prevent post-menopausal bone loss","volume":"51","author":"Reginster","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.maturitas.2005.02.020_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-122-1-199501010-00002","article-title":"Estrogen replacement therapy and fractures in older women","volume":"122","author":"Cauley","year":"1995","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.maturitas.2005.02.020_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9343(94)90050-7","article-title":"Post-menopausal estrogen replacement: a long-term cohort study","volume":"97","author":"Lafferty","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jama.1997.03540310041032","article-title":"Timing of post-menopausal estrogen for optimal bone mineral density. The Rancho Bernardo study","volume":"277","author":"Schneider","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2005.02.020_bib29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"For the CHART study group. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial","volume":"276","author":"Speroff","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2005.02.020_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-106-1-40","article-title":"Post-menopausal bone loss is prevented by treatment with low-dosage estrogen with calcium","volume":"106","author":"Ettinger","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib31","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy. Effects on bone, plasma estradiol concentrations, endometrium, and lipid levels","volume":"157","author":"Genant","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2265.1996.637459.x","article-title":"Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages","volume":"44","author":"Evans","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(97)01110-9","article-title":"Prevention of post-menopausal bone loss with minimal uterine bleeding using low-dose continuous estrogen\/progestin therapy: a 2-year prospective study","volume":"27","author":"Mizunuma","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.02.020_bib34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-130-11-199906010-00005","article-title":"The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: a randomized, controlled trial","volume":"130","author":"Recker","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(91)90538-9","article-title":"Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen","volume":"90","author":"Gallagher","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archinte.162.6.665","article-title":"PEPI Safety Follow-Up study (PSFS) Investigators. Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Post-menopausal Estrogen\/Progestin Interventions (PEPI) Safety Follow-up study","volume":"162","author":"Greendale","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib37","first-page":"9","article-title":"The effects of different dosages of estrogen on the bone mineral density of post-menopausal Hong Kong Chinese women: randomized controlled trial","volume":"5","author":"Leung","year":"1999","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.maturitas.2005.02.020_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultra-low-dose micronized 17\u03b2 estradiol and bone density and bone metabolism in older women","volume":"290","author":"Prestwood","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.maturitas.2005.02.020_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultra-low-dose transdermal estradiol on bone mineral density: a randomized clinical trial","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib40","unstructured":"American Heart Association. 2000. Heart and stroke statistical update. Dallas, TX, American Heart Association. 1999; 1\u201329."},{"key":"10.1016\/j.maturitas.2005.02.020_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinte.1995.00430010063008","article-title":"Risk factors that attenuate the female coronary disease advantage","volume":"155","author":"Kannel","year":"1995","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.maturitas.2005.02.020_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","article-title":"Post-menopausal estrogen and progestin use and the risk of cardiovascular disease","volume":"335","author":"Grodstein","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in post-menopausal women","volume":"117","author":"Grady","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"Hormone replacement therapy, heart disease, and other considerations","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.maturitas.2005.02.020_bib45","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Eng J Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib46","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0003-4975(97)01377-5","article-title":"The biology of estrogen-mediated repair of cardiovascular injury","volume":"65","author":"Selzman","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.maturitas.2005.02.020_bib47","doi-asserted-by":"crossref","unstructured":"Writing group for the PEPI trial. Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in post-menopausal women. The Post-menopausal Estrogen\/Progestin Interventions (PEPI) trial. J Am Med Assoc 1995; 273:199\u2013208.","DOI":"10.1001\/jama.1995.03520270033028"},{"key":"10.1016\/j.maturitas.2005.02.020_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0026-0495(95)90175-2","article-title":"Effects of continuous low-dose hormonal replacement therapy on lipoprotein metabolism in post-menopausal women","volume":"44","author":"Wolfe","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2005.02.020_bib49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.97.10.979","article-title":"Effect of post-menopausal hormone replacement therapy on lipoprotein (a) concentration","volume":"97","author":"Espeland","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2005.02.020_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2265.1999.00857.x","article-title":"The effects of six months of treatment with a low-dose of conjugated estrogens in menopausal women","volume":"51","author":"Schlegel","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.maturitas.2005.02.020_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(01)01829-5","article-title":"Efects of lower-doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism","volume":"76","author":"Lobo","year":"2001","journal-title":"Fertil Steril"},{"issue":"Suppl. A","key":"10.1016\/j.maturitas.2005.02.020_bib52","first-page":"247A","article-title":"Effect of low and standard dose of estrogen replacement therapy upon endothelial function in menopausal women at risk of coronary events (Abstr)","volume":"35","author":"Leonardo","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib53","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jc.2002-021147","article-title":"A comparison of low-dose and standard-dose oral estrogen on forearm endothelial function in early post-menopausal women","volume":"88","author":"Sanada","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2005.02.020_bib54","first-page":"808","article-title":"Lipid profiles and endothelial function with low-dose hormone replacement therapy in post-menopausal women at risk for coronary artery disease: a randomized trial","volume":"108","author":"Mercuro","year":"2003","journal-title":"Inter J Cardio"},{"key":"10.1016\/j.maturitas.2005.02.020_bib55","doi-asserted-by":"crossref","unstructured":"Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. 1996; 348, 977\u201380.","DOI":"10.1016\/S0140-6736(96)07113-9"},{"key":"10.1016\/j.maturitas.2005.02.020_bib56","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of post-menopausal estrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2005.02.020_bib57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0306-4530(92)90007-T","article-title":"Effects of estrogen on memory function in surgically menopausal women","volume":"17","author":"Phillips","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.maturitas.2005.02.020_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1749-6632.1994.tb55794.x","article-title":"Estrogenic effects on memory in women","volume":"743","author":"Sherwin","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.maturitas.2005.02.020_bib59","first-page":"571","article-title":"Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-beta and inflammatory reaction","volume":"31","author":"Thomas","year":"1999","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1749-6632.2000.tb06406.x","article-title":"Vascular actions of estrogen and Alzheimer's disease","volume":"903","author":"Thomas","year":"2000","journal-title":"Ann NY Acad. Sci"},{"key":"10.1016\/j.maturitas.2005.02.020_bib61","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1006\/mcne.1993.1063","article-title":"Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: a basis for potential developmental interactions of estrogen with the neurotrophins","volume":"4","author":"Miranda","year":"1993","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.maturitas.2005.02.020_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/frne.1999.0177","article-title":"Novel mechanisms of estrogen action in the brain: new players in an old story","volume":"20","author":"Toran-Allerand","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(98)00112-1","article-title":"Menopause and the central nervous system: intervention options","volume":"31","author":"Genazzani","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.02.020_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3181\/00379727-217-44200","article-title":"Estrogen and cognitive functioning in women","volume":"217","author":"Sherwin","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.maturitas.2005.02.020_bib65","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00006250-199406000-00017","article-title":"Estrogen use and verbal memory in healthy post-menopausal women","volume":"83","author":"Kampen","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10623329909078493","article-title":"Improvement in functions of the central nervous system by estrogen replacement therapy might be related with an increased nitric oxide production","volume":"6","author":"Lopez-Jaramillo","year":"1999","journal-title":"Endothelium"},{"key":"10.1016\/j.maturitas.2005.02.020_bib67","first-page":"130","article-title":"Low-dose unopposed estrogens: preliminary findings on the frequency and duration of vaginal bleeding in post-menopausal women receiving esterified estrogens over a two-year period","volume":"4","author":"Trabal","year":"1997","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2005.02.020_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5694\/j.1326-5377.1993.tb137744.x","article-title":"Continuous low-dose estrogen and progestogen hormone replacement therapy: a randomized trial","volume":"159","author":"MacLennan","year":"1993","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.maturitas.2005.02.020_bib69","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower-doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2005.02.020_bib70","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0029-7844(96)00272-4","article-title":"Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms","volume":"88","author":"Speroff","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib71","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s001980050159","article-title":"Matrix delivery transdermal 17 \u03b2-estradiol for the prevention of bone loss in post-menopausal women","volume":"9","author":"Cooper","year":"1999","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.maturitas.2005.02.020_bib72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00042192-199704020-00004","article-title":"Minimal endometrial proliferation over a two-year period in post-menopausal women taking 0.3mg of unopposed esterified estrogens","volume":"4","author":"Notelovitz","year":"1997","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2005.02.020_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0029-7844(97)00577-2","article-title":"Risk of endometrial cancer in relation to use of low-dose unopposed estrogens","volume":"91","author":"Cushing","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib74","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.02.020_bib75","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0140-6736(98)10233-7","article-title":"Low-potency estrogen and risk of endometrial cancer: a case-control study","volume":"353","author":"Weiderpas","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.maturitas.2005.02.020_bib76","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1067\/mob.2003.237","article-title":"Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically post-menopausal monkeys","volume":"188","author":"Suparto","year":"2003","journal-title":"Am J Ob Gyn"},{"key":"10.1016\/j.maturitas.2005.02.020_bib77","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Estrogen and ThromboEmbolism Risk study group. Differential association of oral and transdermal estrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2005.02.020_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042192-200310020-00003","article-title":"Role of progestogen in hormone therapy for post-menopausal women: position statement of the North American Menopause Society","volume":"10","author":"Lobo","year":"2003","journal-title":"Menopause"},{"issue":"13","key":"10.1016\/j.maturitas.2005.02.020_bib79","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Women's Health Initiative Investigators","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"5675","key":"10.1016\/j.maturitas.2005.02.020_bib80","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.1096725","article-title":"Hormone therapy: physiological complexity belies therapeutic simplicity","volume":"304","author":"Turgeon","year":"2004","journal-title":"Science"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205000381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205000381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:39:36Z","timestamp":1759912776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512205000381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0378512205000381"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.02.020","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}